Skip to main navigation Skip to search Skip to main content

Magnetic resonance perfusion or fractional flow reserve in coronary disease

  • Eike Nagel
  • , John P. Greenwood
  • , Gerry P. McCann
  • , Nuno Bettencourt
  • , Ajay M. Shah
  • , Shazia T. Hussain
  • , Divaka Perera
  • , Sven Plein
  • , Chiara Bucciarelli-Ducci
  • , Matthias Paul
  • , Mark A. Westwood
  • , Wolf-Stefan Richter
  • , Michael Marber
  • , Valentina O. Puntmann
  • , Carsten Schwenke
  • , Jeanette Schulz-Menger
  • , Rajiv Das
  • , Joyce Wong
  • , Derek J. Hausenloy
  • , Henning Steen
  • Colin Berry, MR-INFORM Investigators, Joseph Brindaban Selvanayagam

Research output: Contribution to journalArticlepeer-review

413 Citations (Scopus)
41 Downloads (Pure)

Abstract

BACKGROUND In patients with stable angina, two strategies are often used to guide revascularization: one involves myocardial-perfusion cardiovascular magnetic resonance imaging (MRI), and the other involves invasive angiography and measurement of fractional flow reserve (FFR). Whether a cardiovascular MRI-based strategy is noninferior to an FFR-based strategy with respect to major adverse cardiac events has not been established.

METHODS We performed an unblinded, multicenter, clinical-effectiveness trial by randomly assigning 918 patients with typical angina and either two or more cardiovascular risk factors or a positive exercise treadmill test to a cardiovascular MRI-based strategy or an FFR-based strategy. Revascularization was recommended for patients in the cardiovascular-MRI group with ischemia in at least 6% of the myocardium or in the FFR group with an FFR of 0.8 or less. The composite primary outcome was death, nonfatal myocardial infarction, or target-vessel revascularization within 1 year. The noninferiority margin was a risk difference of 6 percentage points.

RESULTS A total of 184 of 454 patients (40.5%) in the cardiovascular-MRI group and 213 of 464 patients (45.9%) in the FFR group met criteria to recommend revascularization (P=0.11). Fewer patients in the cardiovascular-MRI group than in the FFR group underwent index revascularization (162 [35.7%] vs. 209 [45.0%], P=0.005). The primary outcome occurred in 15 of 421 patients (3.6%) in the cardiovascular-MRI group and 16 of 430 patients (3.7%) in the FFR group (risk difference, −0.2 percentage points; 95% confidence interval, −2.7 to 2.4), findings that met the noninferiority threshold. The percentage of patients free from angina at 12 months did not differ significantly between the two groups (49.2% in the cardiovascular-MRI group and 43.8% in the FFR group, P=0.21).

CONCLUSIONS Among patients with stable angina and risk factors for coronary artery disease, myocardial-perfusion cardiovascular MRI was associated with a lower incidence of coronary revascularization than FFR and was noninferior to FFR with respect to major adverse cardiac events.

Original languageEnglish
Pages (from-to)2418-2428
Number of pages11
JournalNew England Journal of Medicine
Volume380
Issue number25
DOIs
Publication statusPublished - 20 Jun 2019
Externally publishedYes

Bibliographical note

From Nagel, E., Greenwood, J. P., McCann, G. P., Bettencourt, N., Shah, A. M., Hussain, S. T., … Berry, C. (2019). Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. New England Journal of Medicine, 380(25), 2418–2428. https://doi.org/10.1056/nejmoa1716734
© 2019 Massachusetts Medical Society. Reprinted with permission.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Magnetic resonance perfusion or fractional flow reserve in coronary disease'. Together they form a unique fingerprint.

Cite this